These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 16484825

  • 1. Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption.
    Eming R, Rech J, Barth S, Kalden JR, Schuler G, Harrer T, Hertl M.
    Dermatology; 2006; 212(2):177-87. PubMed ID: 16484825
    [Abstract] [Full Text] [Related]

  • 2. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T, Fujii Y, Ishida A, Handa M, Tanikawa A, Amagai M, Nishikawa T.
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [Abstract] [Full Text] [Related]

  • 3. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M, Chams-Davatchi C, Khamesipour A, Mansoori P, Taheri A, Firooz A, Mortazavi H, Esmaili N, Dowlati Y.
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Five Japanese cases of antidesmoglein 1 antibody-positive and antidesmoglein 3 antibody-negative pemphigus with oral lesions.
    Koga H, Ohyama B, Tsuruta D, Ishii N, Hamada T, Dainichi T, Natsuaki Y, Sogame R, Fukuda S, Karashima T, Tada J, Yamashiro M, Uezato H, Chan PT, Hashimoto T.
    Br J Dermatol; 2012 May; 166(5):976-80. PubMed ID: 22242828
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission.
    Kwon EJ, Yamagami J, Nishikawa T, Amagai M.
    J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1070-5. PubMed ID: 18410336
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies.
    Szabados H, Bősze S, Silló P, Kárpáti S, Hudecz F, Uray K.
    J Pept Sci; 2013 Feb; 19(2):84-94. PubMed ID: 23297065
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of commercially available ELISA assays as a tool for monitoring and managing pemphigus patients: a prospective study.
    Bracke S, Speeckaert R, Van Geel N, De Bacquer D, Lambert J.
    Eur J Dermatol; 2013 Feb; 23(1):33-9. PubMed ID: 23302186
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
    España A, Koga H, Suárez-Fernández R, Ohata C, Ishii N, Irarrazaval I, Teye K, Ohyama B, Hashimoto T.
    Eur J Dermatol; 2014 Feb; 24(2):174-9. PubMed ID: 24776707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.